A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 clinical study evaluating the safety and effectiveness of SP-624 as
compared to placebo in the treatment of adults with Major Depressive Disorder.